You must cast your vote by 5:00pm EDT on June 17, 2019 - Voting is now closed!
|Click on "Vote Now" at the bottom of this page
Click here to view the current officers
Please choose one candidate for President-elect:
Masanori Aikawa, M.D., Ph.D.
Associate Professor of Medicine (HMS)
Yoshihiro Miwa Associate Chair & Founding Director
Center for Interdisciplinary Cardiovascular Sciences (BWH)
Brigham and Women's Hospital and Harvard Medical School
Research Interests: macrophage biology, inflammation, systems biology, target discovery.
NAVBO activities: Member since 1994; Member, Development Committee 2014-2016; Chair, Development Committee 2014-2016; Member, Meritorious Awards Committee 2018-present; Co-Organizer, IVBM 2016 ; Chair, Sponsorship Committee, IVBM 2016; Organizer, Vascular Inflammation Workshop, Vascular Biology 2018 (PI of a successful application for an NIH R13 grant).
Related Experience: Member, Executive Council, International Society for Applied Cardiovascular Biology (ISACB) 2008-present; Chair, Organizing Committee, ISACB 2020 (Tokyo); Committee Member, Seminars in Vascular Biology, Harvard Medical School 2005-present; Past and present editorial positions: Circulation, Circulation Research, ATVB, JACC, PLOSONE, Cardiovascular Research, and Frontiers in Cardiovascular Medicine (Co-Chief Editor); Past and present memberships at grant review committees: NIH/NHLBI AICS, AHA Vascular Wall Biology, VA Merit Grants, Deutsche Forschungsgemeinschaft (DFG) Grants, and AMED-CREST Program (Japan).
Masanori's Vision for NAVBO
I have been a NAVBO member for 25 years, having joined this society in 1994 when I was a PhD student at the University of Tokyo. Since then, I have been an active participant and have done what I can to contribute to NAVBO‘s impressive growth by delivering many talks at annual meetings and arranging for my fellows to participate in meetings and webinars. I have been fortunate enough to be able to play leadership roles as a co-organizer of IVBM 2016 and Vascular Biology 2018, contributing to both scientific programing and the financial success of these meetings. As a participant in various NAVBO activities, I have developed ideas for how I can work together with all NAVBO members to strengthen our society and take it to the next level.
1. We must continue to strive for diversity and support careers of women scientists. NAVBO has been successful in this mission but there is more to be done. I will particularly focus on further supporting women scientists. I propose to launch a new Committee for Diversity, where we can proactively discuss how to support the career development of women, as well as internationally-trained scientists, minorities and other diverse groups and find more ways for involving them in leadership roles in NAVBO.
2. We must find ways for increasing support for young investigators. Under the current funding climate, all of us are finding it difficult to acquire adequate funding, but junior investigators particularly have been hit hard. I believe NAVBO can help young scientists get funded successfully and establish their careers more rapidly. When programing our conferences, we will allocate more timeslots for new sessions, including short lectures, interactive discussions, and individual senior advisors’ tables, that focus on grant writing or career advice. We can consider launching quarterly career development or grantsmanship webinars. I also propose to form a working group involving senior, mid-career, and junior members who are interested in considering these and other ideas to accomplish this goal.
3. Increased consideration to translational implications. NABVO’s success depends on its strong roots in innovative basic science investigations. Research progress that has emerged fundamental biology is our strength and will furnish the basis for additional progress in furthering our understanding of vascular biology. We have an opportunity, however, to exploit these advances to spur innovation in the prevention and treatment of cardiovascular diseases. I thus would encourage building on the basic science foundation increased consideration of translational applications of our science to the clinic by incorporating some more translational components in our meetings and webinars. By continuing our commitment to basic science but at the same time thinking creatively about the translation of fundamental knowledge to clinical applications, NAVBO will strengthen its position as an important organization within the broad field of medicine.
4. Let’s learn new technologies together. The speed of technological development is increasing exponentially. Learning how to use new technologies, such as artificial intelligence, may help us identify more promising therapeutic targets, speed up translation of basic science into the clinic, and increase its success rates in clinical development. I believe the Bioinformatics Boot Camp at Vascular Biology 2018 was a great success. NAVBO has high potential to become an exciting interface between vascular biology and data science. I would like us to continue to extend our scope in this direction to learn innovative technologies together from pioneers so we can implement them in our research.
5. Networking with other communities is important. To further strive for diversity and learn new approaches, continuing to partner with other organizations is critical. We have enjoyed successful associations with other scientific communities, including the Microcirculatory Society, Lymphatic Education & Research Network, and the International Society for Applied Cardiovascular Biology (ISACB). As a co-chief editor of Frontiers in Cardiovascular Medicine, I initiated a unique partnership between NABVO and the journal that can facilitate sharing new ideas and concepts among investigators. I believe expanding our network further with other communities and sectors will help NAVBO increase not only its diversity but also global recognition.
Guillermo Oliver, Ph.D.
Director, Northwestern University Regenerative Biology & Stem Cells Initiative
Thomas D. Spies Professor of Lymphatic Metabolism
Director, Center for Vascular and Developmental Biology
Feinberg Cardiovascular Institute
Northwestern Feinberg School of Medicine
Research Interests: My laboratory focuses in understanding the cellular and molecular mechanisms controlling organ formation in mammals. Almost 20 years ago, we identified the transcription factor Prox1 as a central player in the formation and maintenance of the mammalian lymphatic vasculature. We also identified a novel role for the lymphatic vasculature in metabolism and obesity, and generated a variety of animal models that become valuable tools for the vascular research community.
Main topics of interest: Organogenesis, vascular biology and lymphangiogenesis in health and disease, endothelial cell plasticity, stem cells-derived 3D.
NAVBO Activities: Member since 2007; Councilor – 2015-2016; Organizer – Lymphatic Forum 2017; International Scientific Program Committee – IVBM 2016.
Related Experience: 2007 Co-Chairman of the National Institutes of Health "Working Group for Lymphatic Research”; 2009-2015 Elected Member of the Board of Directors of the American Society of Developmental Biology; 2010 Organizer, First Cold Spring Harbor Symposia in Vertebrate Organogenesis (Cold Spring Harbor, New York); Fellow, American Association for the Advancement of Sciences (2011, AAAS); Lymphatic Research Foundation Leadership Award (2008, Lymphatic Research Foundation); 2012 Chair, Gordon Research Conference in Lymphatic Research (Ventura, CA); 2012 Co-organizer second Cold Spring Harbor Symposia in Vertebrate Organogenesis in Health & Disease; 2019 Co-organizer 10th Latin America Society of Developmental Biology Meeting (Buenos Aires, Argentina).
I have been a member of the Board of Directors of the American Society of Developmental Biology and have ample experience in the organization of meetings and fundraising. Among other ones, I participated in the first Trans-NIH coordinating committee for Lymphatic Research in 2007, organized the 2012 Gordon Research Conference in Lymphatic Research, and started and chaired the Cold Spring Harbor Symposia in Vertebrate Organogenesis in Health and Disease (2010 and 2012).
Guillermo's Vision for NAVBO
Those of us working in the field of vascular biology chose this research topic for different reasons. Some were driven by an interest in addressing basic questions. Others were interested in more clinical-oriented aspects. Yet others, like myself, landed on the topic by accident upon identifying the role of Prox1 in lymphatic development. Regardless of our “different lineages,” we all share a common passion for and curiosity about this research topic, which falls under the broad umbrella of the NAVBO mission: to promote the study of vascular biology.
I am convinced that despite the frustrating funding challenges, now is a great time to be a scientist. We have at our disposal a remarkable array of tools and technologies, allowing us to tackle ever more ambitious questions. However, this same progress comes hand in hand with new challenges, highlighting the importance of the NAVBO mission. Accordingly, I have outlined a number of priority goals:
1. Research is more multidisciplinary than ever before, and previous NAVBO presidents have done a great job of broadening the scope of our research field. Now more than ever, we should continue this trend and engage investigators and clinicians working in both academia and industry and having diverse research backgrounds to participate in our flag NAVBO meetings and courses. We can all benefit from the intellectual and technological input of colleagues taking diverse approaches to address basic and translational questions. Engagement from these sectors will also help bridge the bench-to-bedside divide and encourage interactions with others with complementary interests.
2. NAVBO should continue to serve as the main communication hub for stimulating and supporting the next generations of vascular biologists. NAVBO conferences should build upon their history of providing a unique opportunity for trainees and young investigators to discuss their work and gain a name in the vascular biology community. At the same time, we should also get as much feedback as possible from trainees and starting faculty about their vision and concerns. Based on this feedback and from my own experience as a council member for the Society of Developmental Biology, I will consider the implementation of pre-conference training camps for pre-tenure faculty, as well as for advanced postdoctoral fellows about to begin their first academic position. This should be a valuable opportunity to listen to their opinions and concerns, as well as to help them improve leadership and management and learning about teaching and mentoring.
3. NAVBO should be a vocal advocate in issues related to NIH funding by taking advantage of our available resources (conferences, website, YouTube videos). We should consider including our local community and government representatives during some of our established activities as a means of engaging with and educating them in the importance of vascular biology research. .
Please choose two candidates for Council:
Christopher V. Carman, Ph.D.
Program in Molecular & Integrative Physiologic Science
Center for Nanotechnology
Harvard School of Public Health
Research interests: Regulation of the trafficking of immune & stem cells by the vasculature in inflammation; Endothelial barrier homeostasis and wound healing; Adaptive immune functions of the endothelium; and Novel targeted and cellular therapeutic for inflammatory disease
NAVBO Activities: Member since 2013; frequently attended and presented research at the Annual Vascular Biology Meeting through posters and/or selected talks; More recently, I have served as both session chair and invited speaker.
Related experience: Member/Organizer, Harvard Vascular Biology Seminars Committee (2008-2017); Chair, CVBR Annual Retreat Committee (2014-2016); Chair/Organizer, Boston Angiogenesis Meeting (2015); Mentor/Teacher/Developer, CVBR Career Development Workshops (2012-2016); Member, BIDMC Center for Vascular Biology Research (CVBR) Planning Committee (2006-08); Chair, CVBR Outreach/Website Committee (2006-16); Member, Harvard Immunology Resources Committee (2007-11); Member, CVBR Seminars Planning Committee (2007-08)
Hyung Chun, Ph.D
Associate Professor of Medicine and Pathology
Research Interests: Vascular biology; pulmonary hypertension; diabetes; endothelial signaling; atherosclerosis
NAVBO Activities: Member since 2010; attendee and presenter at multiple NAVBO Vascular Biology meetings; recipient of the Springer Junior Investigator Award.
Related Experience: Leadership Committee of the AHA 3CPR Council; Reviewer & Co-Chair (2016), NIH Center for Scientific Review RIBT, Special Emphasis Panel ZRG1 CVRS, ZHL1 PPG-S (2014-2016); Member, AHA Innovative Research Grant (2016-) and AHA Established Investigator Award (2018-) Committees; Editorial Board: Pulmonary Circulation, Frontiers in Cardiovascular Medicine; Director of Translational Research, Yale Pulmonary Vascular Disease Program; Fellow of the American Heart Association; Member, American Society of Clinical Investigation; Co-Director, Yale T32 Vascular Biology Training Program
Tsutomu Kume, Ph.D
Professor of Medicine (Cardiology) and Pharmacology
Feinberg Cardiovascular and Renal Research Institute
Northwestern University School of Medicine
Research interests: Blood and lymphatic vessel development; transcriptional control of vascular gene expression; vascular cell signaling; angiogenesis; lymphangiogenesis; vascular homeostasis and dysfunction
NAVBO Activities: Member since 2007; Representative (2011-present) ; Education Committee Member (2015-2018); Co-Organizer, Vasculata 2017; Session Chair, Vascular Biology 2017 and 2018; Poster Presenter, Speaker and Poster Judge at NAVBO meetings
Related experience: Ad hoc Reviewer for NIH/NHLBI Special Emphasis Panel (SEP), Cardiovascular Differentiation and Development (CDD) and Vascular Cell and Molecular Biology (VCMB) Study Sections (2011-2017); Charter Member for NIH/NHLBI VCMB Study Section (2017-2021); Reviewer for AHA (2009-), Molecular Signaling, Vascular Wall Biology AAGI Basic Science, National Established Investigator Award (EIA)- Basic Sciences, Career Development Award - Basic Vascular Sciences
Linda Shapiro, Ph.D.
Director, Center for Vascular Biology
Professor, Department of Cell Biology
Marlene L. Cohen and Jerome Fleish Faculty Scholar
University of Connecticut School of Medicine
Research interests: cell-cell communication in inflammation and vascular biology
NAVBO Activities: Member since 2010; Education Committee (2017-2019) and Webinar Moderator (2018-2019); Poster judge (2015); Editor, Vascular Biology Publications Alert (2018-present)
Related Experience: Charter Member, Atherosclerosis and Inflammation in the Cardiovascular System (AICS) Study Section, National Institutes of Health 2006-2010; NIDDK George M. O'Brien Kidney Research Core Center P30 Review 2017; Continuous submission status based on ‘substantial service to peer review at the NIH’, 2014-2016; NHLBI R15 review, 2013-2017; AHA Student Fellowship Review, 2014, 2015,2016; NCI Fellowship Review, 2014, 2015; Ad Hoc Reviewer- Vascular Cellular and Molecular Biology (VCMB) study section 2013-2017; Member, Editorial Board, Journal of Biological Chemistry, 2007-2012; Member, Research Committee, Founder’s Affiliate, American Heart Association; Member, Executive Leadership Committee, American Heart Association of Greater Hartford.
Cynthia St. Hilaire, Ph.D.
Division of Cardiology
Department of Bioengineering
Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute
Research interests: vascular calcification; valvular calcification; vascular tortuosity/aneurysm; cell phenotype transition
NAVBO Activities: Member since 2011; Invited to present at 2010, 2011, 2012, 2016, and 2017 IVBM/NAVBO meetings; Co-Chaired 2015 Vascular Matrix Calcification Session.
Related experience: Vice-Chair of the ATVB Early Career Committee; Co-Chair of the ISACB Women's Leadership Committee; Member of the ATVB Women's Leadership Committee; former member of the ATVB Nominations & Awards Committee; standing member of Department of Veterans Affairs Scientific Review Group ZRD1 CARB-R (01) Cardiology – B
Radu Stan, M.D., Ph.D
Department of Biochemistry and Cell Biology
The Geisel School of Medicine at Dartmouth
Research Interests: vascular biology; endohelial barrier function; role of endothelium in recruiting the tumor microenvironment in cancer
NAVBO activities: Member since 2000; Annual Meeting Program Committee (2009); Meritorious Awards Committee (2009-12); NAVBO Council (2013-2016); Communications Committee (2012-); senior editor of the Vascular Biology Publicatins Alert
Related Experience: Adhoc Reviewer for NIH/CSR Atherosclerosis and Inflammation in the Cardiovascular System (AICS) (2008-2010); Vascular Cell and Molecular Biology (VCMB) (2010- ) and Cancer Immunology and Immunotherapy (CII) Study Sections (2015- ); Ad hoc Reviewer on Special Emphasis Panels (SEP) for NIH/NHLBI, NIH/NIEHS, NIH/OD andNIH/NCI; Reviewer for AHA Founders (2018-present).
Cast your vote by 5:00pm EDT on June 17, 2019
Only Regular Members may vote